Sales declined 7% from the second quarter of 2026.

Reported diluted earnings per share from continuing operations were $0.68, compared with a loss of $12.39 per share in the prior-year quarter, which included significant impairment charges.

Adjusted diluted earnings per share increased to $1.65 from $1.34 a year earlier but declined from $2.45 in the second quarter.

Celanese reported consolidated operating profit of $198 million, adjusted EBIT of $367 million and operating EBITDA of $548 million.

The company said improved commercial execution, productivity initiatives and strategic growth programs helped support results.

Acetyl Chain Sales Increase on Higher Prices

Celanese's Acetyl Chain business reported third-quarter sales of $1.21 billion, an increase of approximately 14% from $1.06 billion in the prior-year quarter.

The business includes acetic acid, derivatives and vinyl-chain products used as chemical intermediates in coatings, adhesives and other formulated materials.

Celanese reported strong performance across acetic acid, derivatives and the vinyls chain.

Higher selling prices and incremental spot-market opportunities more than offset modest demand softness.

Year-over-year Acetyl Chain sales growth was driven by a 14% increase in pricing, while volumes were approximately unchanged.

The results provide additional context for coatings manufacturers monitoring chemical intermediates such as acetic acid, vinyl acetate monomer and ethyl acetate.

Those materials are used in downstream resin, emulsion, solvent and other formulation applications.

Sequential Results Show Moderation

Despite higher year-over-year sales, Acetyl Chain revenue declined 9% from the second quarter of 2026.

Sequential volumes declined 4%, while average selling prices fell 5%.

Celanese attributed the moderation to supply chains returning toward more normal conditions following a period of volatility.

Acetyl Chain operating profit totaled $141 million, compared with $135 million a year earlier and $237 million in the second quarter.

Adjusted EBIT increased to $236 million from $187 million a year earlier but declined from $321 million sequentially.

Operating EBITDA totaled $301 million, representing a 25% margin.

The results demonstrate that stronger year-over-year pricing can coexist with weakening sequential market conditions.

Celanese said its integrated manufacturing network and ability to shift production and commercial activity across regions helped the business respond to changing market conditions.

Engineered Materials Reports Mixed Demand

The Engineered Materials segment reported sales of $1.37 billion, compared with $1.38 billion in the third quarter of 2025.

The 1% year-over-year decline was affected by the previously divested Micromax business, which contributed to the comparison.

Growth in medical and electronics applications supported product mix and earnings.

However, automotive market demand moderated sequentially.

Engineered Materials revenue declined 5% from the second quarter, primarily because of lower automotive volumes, partially offset by demand in medical and electronics applications.

Operating profit totaled $161 million, while adjusted EBIT reached $209 million and operating EBITDA totaled $311 million.

The company said favorable product mix, commercial execution and early contributions from strategic growth initiatives helped offset raw-material inflation and higher logistics costs.

Celanese also reported progress on manufacturing projects intended to support growth in specialty materials.

These include an expansion of specialty compounding operations in Europe, commissioning activities for a liquid crystal polymer facility in Asia and additional medical-grade compounding capabilities in Asia.

The company expects the three projects to be commercialized during the first half of 2027.

Cash Flow and Portfolio Changes

Celanese generated $538 million in operating cash flow during the third quarter, compared with $447 million a year earlier.

Free cash flow increased to $461 million from $5 million.

For the first nine months of 2026, operating cash flow totaled $823 million and free cash flow reached $604 million.

The company continues to prioritize debt reduction through cash generation, productivity improvements and selected portfolio divestitures.

Celanese said it is targeting approximately $1 billion in total divestiture proceeds by the end of 2027 and expects proceeds to reach approximately $650 million by the end of 2026.

As part of those efforts, the company signed a definitive agreement to sell an additional 19% interest in its Nutrinova food ingredients joint venture to Mitsui & Co., Ltd.

The transaction is expected to generate approximately $152 million in cash proceeds, with Celanese retaining an 11% interest.

Closing is expected during the fourth quarter of 2026, subject to regulatory approvals and other customary conditions.

The company also completed the previously announced closure of its acetate tow manufacturing facility in Lanaken, Belgium, as part of manufacturing footprint optimization.

Celanese Raises 2026 Outlook

Celanese now expects full-year adjusted earnings per share between $6.00 and $6.25.

The company also increased its full-year free cash flow outlook to $750 million-$800 million.

Management expects seasonal moderation in both Engineered Materials and Acetyl Chain during the fourth quarter.

Celanese anticipates ending 2026 with a net debt-to-operating EBITDA ratio of approximately 4.7.

The company plans to provide additional information about its longer-term strategy at a December 9 investor event at its technical center and manufacturing site in Florence, Kentucky.

The presentation is expected to address growth opportunities, operating priorities and plans for long-term value creation.

Celanese's latest results underscore the importance of distinguishing pricing-led revenue growth from underlying demand trends when evaluating chemical supplier performance.

For coatings manufacturers, movements in acetyl-chain pricing can affect raw-material costs across several resin, solvent and formulated-product categories.

Celanese's Acetyl Chain results provide another indicator of chemical input pricing and demand conditions affecting coatings manufacturers. Follow additional developments in PCI's paint and coating resins and polymers coverage.